Pharmaceutical Technology-05-02-2020

Pharmaceutical Technology

Can We Teach an Old Drug New Tricks?

May 02, 2020

From the Editor

44

5

In light of the hype around chloroquine and hydroxychloroquine as potential COVID-19 treatments, it is important to remember that drug repurposing should never be rushed, irrespective of the urgency of the situation.

Can EMA’s Regulatory Science Strategy Meet Medicine’s Major Challenges?

May 02, 2020

Regulatory Watch

44

5

EMA’s strategy for regulatory science has divided opinion amongst various industry bodies.

Small-Volume Conversion Kit for Bathless Dissolution Testers

May 02, 2020

Product Spotlight

44

5

Distek’s small-volume conversion kit for its Model 2500 Select bathless dissolution tester uses bathless heating technology and the continuous monitoring and control of the in-vessel temperature to eliminate the water bath in the dissolution tester.

Pre-Packed Columns

May 02, 2020

Product Spotlight

44

5

Tosoh Bioscience introduced the SkillPak 1 mL and 5 mL pre-packed columns for fast method development and resin screening of monoclonal antibodies, antibody constructs, oligonucleotides, proteins, and viruses.

How Fast Is Too Fast?

May 02, 2020

From the Editor

44

5

Will moving at “warp speed” to develop a vaccine impact efficacy or safety?

Contamination Drives a More Concerted Approach to Genotoxins

May 02, 2020

Analytics

44

5

Discovery of carcinogenic nitrosamines in three of the world’s most widely prescribed drugs is driving efforts to better detect, control and prevent their generation in APIs and finished drug products.

Modern Drug Manufacturing Key to COVID-19 Response

May 02, 2020

Regulatory Watch

44

5

Policy makers seek to ensure supplies of new therapies and to limit shortages.

Starting a Career in the Bio/Pharmaceutical Industry

May 02, 2020

Ask the Expert

44

5

Having a better understanding about compliance will be of benefit when looking for a job or for furthering one’s career, says Siegfried Schmitt, PhD, vice-president, technical, Parexel Consulting.

Determining the Probability of Passing USP Content Uniformity and Dissolution - Immediate and Extended - Tests with CuDAL-Excel

May 02, 2020

Peer-Review Research

44

5

The CuDAL-Excel program, based on Microsoft (MS) Excel, has been developed to calculate the United States Pharmacopeia (USP) passing probability of content uniformity and dissolution tests for both sampling plan 1 and sampling plan 2 scenarios and for both immediate release and extended release requirements. The users can obtain the passing probability by simply entering the input variables, with wide applications for process validation/verification and batch release. As a user-friendly program, CuDAL‑Excel should bring more benefits to the industry practitioners than other existing programs/tools.

Pharmaceutical Technology North America, May 2020 (PDF)

May 02, 2020

Issue PDF

44

5

Click the title above to open the Pharmaceutical Technology May 2020 issue in an interactive PDF format.